High mobility group box protein-1 (HMGB-1) as a new diagnostic marker in patients with acute appendicitis

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

Volumn 19, Issue , 2011, Pages

  Albayrak, Yavuz ^a   Albayrak, Ayse ^a   Celik, Muhammet ^b   Gelincik, Ibrahim ^a   Demiryilmaz, Ismail ^c   Yildirim, Rahsan ^b   Ozogul, Bunyami ^a  

^a Erzurum Region Education and Research Hospital   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HIGH MOBILITY GROUP B1 PROTEIN;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; APPENDICITIS; ARTICLE; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; TURKEY (REPUBLIC);

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; APPENDICITIS; BIOLOGICAL MARKERS; FEMALE; HMGB1 PROTEIN; HUMANS; MALE; MIDDLE AGED; ROC CURVE; TURKEY; YOUNG ADULT;

EID: 79954610852     PISSN: None     EISSN: 17577241     Source Type: Journal    
DOI: 10.1186/1757-7241-19-27     Document Type: Article

References (33)

1. Hardin DM. Acute appendicitis: review and update. Am Fam Phys 1999, 60:2027-2034.
2. Blewett JC, Krummel TM. Perforated appendicitis: past and future controversies. Semin Pediatr Surg 1995, 4:234-238.
3. Smink DS, Finkelstein JA, Garcia BM, et al. Diagnosis of acute appendicitis in children using a clinical practice guideline. J Pediatr Surg 2004, 39:458. 10.1016/j.jpedsurg.2003.11.015, 15017570.
4. Kharbanda AB, Taylor GA, Fishman SJ, Bachur RGA. Clinical Decision Rule to Identify Children at Low Risk for Appendicitis. Pediatrics 2005, 116:709. 10.1542/peds.2005-0094, 16140712.
5. Mikaelsson C, Arnbjörnsson E. The value of C-reactive protein (CRP) determinations in patients with suspected acute appendicitis. Ann Chir Gynaecol 1984, 73:281.
6. Albayrak Y, Albayrak A, Albayrak F, et al. Mean Platelet Volume: A New Predictor in Confirming Acute Appendicitis Diagnosis. Clin Appl Thromb Hemost
7. Tzanakis NE, Efstathion SP, Danulidis K, et al. A new approach to accurate diagnosis of acute appendicitis. World J Surg 2005, 29:1151-1156. 10.1007/s00268-005-7853-6, 16088420.
8. Amalesh T, Shankar M, Shankar R. CRP in acute appendicitis--is it a necessary investigation?. Int J Surg 2004, 2:88-89. 10.1016/S1743-9191(06)60050-2, 17462226.
9. Weyant MJ, Eachempati SR, Maluccio MA, et al. Interpretation of computed tomography does not correlate with laboratory or pathologic findings in surgically confirmed acute appendicitis. Surgery 2000, 128:145-152. 10.1067/msy.2000.107422, 10922984.
10. Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000, 192:565-570. 10.1084/jem.192.4.565, 2193240, 10952726.
11. Park JS, Arcaroli J, Yum HK, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003, 284:870-879.
12. Bustin M. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci 2001, 26:152-153.
13. Johns EW. The HMG Chromosomal Proteins. 1992, London, Academic Press.
14. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251. 10.1126/science.285.5425.248, 10398600.
15. Yang H, Ochani M, Li J, et al. Reversing established sepsis with antagonists of endogenous highmobility group box 1. Proc Natl Acad Sci, USA 2004, 101:296-301. 314179, 14695889.
16. Abraham E, Arcaroli J, Carmody A, et al. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165:2950-2954.
17. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cell triggers inflammation. Nature 2002, 418:191-195. 10.1038/nature00858, 12110890.
18. O'Connor KA, Hansen MK, Rachal C, et al. Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. Cytokine 2003, 24:254-265. 10.1016/j.cyto.2003.08.001, 14609567.
19. Andersson U, Tracey KJ. HMGB1 in sepsis. Scand J Infect Dis 2003, 35:577-584. 10.1080/00365540310016286, 14620138.
20. Yang H, Wang H, Czura CJ, Tracey KJ. The cytokine activity of HMGB1. J Leukoc Biol 2005, 78:1-8. 10.1189/jlb.1104648, 15734795.
21. Kokkola R, Sundberg E, Ulfgren AK, et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 2002, 46:2598-2603. 10.1002/art.10540, 12384917.
22. Taniguchi N, Kawahara K, Yone K, et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 2003, 48:971-981. 10.1002/art.10859, 12687539.
23. Hatada T, Wada H, Kobayashi T, et al. High mobility group box protein is increased in the plasma and may have a role in development of organ failure in DIC. (Elevated plasma levels of high mobility group B-1 (HMGB-1) in patients with disseminated intravascular coagulation (DIC) and those with organ failure (OF). Thromb Haemost 2005, 94:975-979.
24. Goldstein RS, Bruchfeld A, Yang L, et al. Cholinergic Anti- Inflammatory Pathway Activity and High Mobility Group Box-1 (HMGB1) Serum Levels in Patients with Rheumatoid Arthritis. Mol. Med 2007, 13:210-215.
25. Goldstein RS, Gallowitsch-Puerta M, Yang L, et al. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 2006, 25:571-574. 10.1097/01.shk.0000209540.99176.72, 16721263.
26. Bruchfeld A, Qureshi AR, Lindholm B, et al. High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD). Mol Med 2008, 14:109-115. 10.1007/s00894-007-0256-x, 2258159, 18317568.
27. Hiroshi U, Tomoyuki M, Satoru H, et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004, 170:1306-1310.
28. Angus DC, Yang L, Kong L, et al. Circulating high-mobility group box-1 (HMGB-1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med 2007, 35:1061-1067. 10.1097/01.CCM.0000259534.68873.2A, 17334246.
29. Albayrak A, Uyanik MH, Cerrah S, et al. Is HMGB1 a New Indirect Marker for Revealing Fibrosis in Chronic Hepatitis and a New Therapeutic Target in Treatment?. Viral Immunol 2010, 23:633-638. 10.1089/vim.2010.0080, 21142449.
30. Gaïni S, Koldkjaer OG, Møller HJ, et al. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study. Crit Care 2007, 11(4):R76. 10.1186/cc5967, 2206511, 17625012.
31. Yang H, Wang H, Trachey KJ. HMG-1 rediscovered as a cytokine. Shock 2001, 15:247-253. 10.1097/00024382-200115040-00001, 11303722.
32. Yasuda T, Ueda T, Takeyama Y, et al. Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas 2006, 3:359-363.
33. Kosai K, Seki M, Yanagihara K, et al. Elevated levels of high mobility group box chromosomal protein-1 (HMGB-1) in sera from patients with severe bacterial pneumonia coinfected with influenza virus. Scand J Infect Dis 2008, 40:338-342. 10.1080/00365540701660486, 17918013.